노벨티노빌리티
1 known investors
Novelty Nobility develops antibody therapeutics using its PREXISE-D platform for fit-for-purpose antibody design and discovery, including antibody-drug conjugates aimed at overcoming drug resistance. The company also pursues treatments related to ophthalmic conditions.
Investors · 1
Frequently asked questions
- What does 노벨티노빌리티 do?
- Novelty Nobility develops antibody therapeutics using its PREXISE-D platform for fit-for-purpose antibody design and discovery, including antibody-drug conjugates aimed at overcoming drug resistance. The company also pursues treatments related to ophthalmic conditions.
- Who are 노벨티노빌리티's investors?
- 노벨티노빌리티's investors include Solidus Investment.